(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÕES DE GEL LÍQUIDO CONCENTRADO CONTENDO SAIS DE NAPROXENO

ArquivadaInvention PatentPCT · US2022070112

Application data

Number

112023013041

Type

Invention Patent

Filing

01/10/2022

Publication

08/01/2023

PCT

US2022070112

Progress at the INPI

  1. Filing01/10/22
  2. Publication08/01/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 01/10/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BAYER HEALTHCARE LLC

US

See this company's full portfolio

Inventors

A. E. (pessoa física)

US

B. M. (pessoa física)

ES

M. P. (pessoa física)

ES

M. S. (pessoa física)

ES

Technical data

Priority claims

US

63/135,885 · 01/11/2021

Abstract

FORMULAÇÕES DE GEL LÍQUIDO CONCENTRADO CONTENDO SAIS DE NAPROXENO. A presente invenção se refere a cápsulas de minigel macio, particularmente cápsulas gelatinosas macias contendo sal de naxopreno como um ingrediente ativo. Se refere, em geral, a cápsulas gelatinosas macias, que contêm formulações de alta concentração de sódio de naproxeno.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

04/08/2025

RPI 2831

Arquivamento - Art. 33 da LPI

#11.1

01/21/2025

RPI 2820

Notificação de entrada na fase nacional - PCT

#1.3

08/01/2023

RPI 2743

Alteração de dados cadastrais

#1.1

07/11/2023

RPI 2740

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.